Zhenyu Ding Selected Research

Hand-Foot Syndrome

1/2020

A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenyu Ding Research Topics

Disease

23	Neoplasms (Cancer) 04/2023 - 08/2006
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 05/2014
6	Neoplasm Metastasis (Metastasis) 06/2022 - 12/2017
5	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2018
5	Carcinoma (Carcinomatosis) 01/2020 - 09/2009
4	Colonic Neoplasms (Colon Cancer) 12/2022 - 08/2006
3	Esophageal Squamous Cell Carcinoma 11/2023 - 01/2021
3	Esophageal Neoplasms (Esophageal Cancer) 04/2023 - 04/2013
3	Disease Progression 06/2022 - 08/2013
3	Adenocarcinoma of Lung 01/2022 - 07/2017
3	Brain Neoplasms (Brain Tumor) 12/2018 - 05/2014
3	Hypoxia (Hypoxemia) 02/2017 - 11/2010
3	Carcinogenesis 01/2015 - 06/2009
3	Colorectal Neoplasms (Colorectal Cancer) 04/2013 - 09/2009
2	Infections 11/2021 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2021 - 07/2017
2	Hypertension (High Blood Pressure) 10/2020 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018 - 08/2013
2	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2022
1	Endocrine System Diseases (Endocrine Diseases) 01/2022
1	Nasopharyngeal Carcinoma 01/2022
1	Osteoarthritis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Virus Diseases (Viral Diseases) 11/2021
1	Squamous Cell Carcinoma of Head and Neck 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2021
1	Complementation Group C Xeroderma Pigmentosum 01/2021
1	Angina Pectoris 10/2020
1	Hyperlipidemias (Hyperlipidemia) 10/2020
1	Myocardial Infarction 10/2020
1	Inflammation (Inflammations) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Coronavirus Infections 01/2020
1	Hand-Foot Syndrome 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	COVID-19 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 04/2019
1	Dermatofibrosarcoma 04/2019
1	Radiation Pneumonitis 01/2019
1	Chronic Renal Insufficiency 04/2018
1	Pleural Effusion (Pleural Effusions) 01/2018

Drug/Important Bio-Agent (IBA)

8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2011
6	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2021
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2016
4	Messenger RNA (mRNA)IBA 12/2022 - 11/2010
4	VaccinesIBA 01/2021 - 06/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2012
3	AntigensIBA 12/2020 - 06/2011
2	Gemcitabine FDA Link 01/2022 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
2	Peptides (Polypeptides)IBA 01/2021 - 01/2020
2	apatinibIBA 01/2020 - 04/2019
2	AntibodiesIBA 02/2018 - 08/2006
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014 - 11/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2022
1	mRNA VaccinesIBA 12/2022
1	osimertinibIBA 01/2022
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2022
1	SugarsIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	GelatinIBA 10/2021
1	pirfenidoneIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	Programmed Cell Death 1 ReceptorIBA 02/2021
1	Long Noncoding RNAIBA 01/2021
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 12/2020
1	anlotinibIBA 10/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	PlatinumIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	CrizotinibIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2019
1	CreatinineIBA 04/2018
1	Cystatin CIBA 04/2018
1	Bevacizumab (Avastin)FDA Link 04/2018
1	EndostatinsIBA 01/2018
1	NivolumabIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Durapatite (Hydroxylapatite)IBA 02/2017
1	Phosphocreatine (Neoton)IBA 02/2017

Therapy/Procedure

10	Immunotherapy 12/2022 - 06/2009
10	Therapeutics 01/2022 - 06/2011
8	Drug Therapy (Chemotherapy) 11/2023 - 01/2014
5	Radiotherapy 01/2019 - 05/2014
3	Neoadjuvant Therapy 11/2023 - 01/2022
1	Induction Chemotherapy 01/2022
1	Adjuvant Radiotherapy 04/2019
1	Chemoradiotherapy 01/2018
1	Microspheres (Microsphere) 02/2017